Département de Pathologie et Microbiologie, Faculté de Médecine Vétérinaire, Université de Montréal Saint-Hyacinthe, QC, Canada ; Centre de Recherche en Infectiologie Porcine et Avicole, Université de Montréal Saint-Hyacinthe, QC, Canada.
Front Microbiol. 2014 Apr 22;5:183. doi: 10.3389/fmicb.2014.00183. eCollection 2014.
Clostridium perfringens is an opportunistic pathogen that can cause food poisoning in humans and various enterotoxemia in animal species. Very little is known on the biofilm of C. perfringens and its exposure to subminimal inhibitory concentrations of antimicrobials. This study was undertaken to address these issues. Most of the C. perfringens human and animal isolates tested in this study were able to form biofilm (230/277). Porcine clinical isolates formed significantly more biofilm than the porcine commensal isolates. A subgroup of clinical and commensal C. perfringens isolates was randomly selected for further characterization. Biofilm was found to protect C. perfringens bacterial cells from exposure to high concentrations of tested antimicrobials. Exposure to low doses of some of these antimicrobials tended to lead to a diminution of the biofilm formed. However, a few isolates showed an increase in biofilm formation when exposed to low doses of tylosin, bacitracin, virginiamycin, and monensin. Six isolates were randomly selected for biofilm analysis using scanning laser confocal microscopy. Of those, four produced more biofilm in presence of low doses of bacitracin whereas biofilms formed without bacitracin were thinner and less elevated. An increase in the area occupied by bacteria in the biofilm following exposure to low doses of bacitracin was also observed in the majority of isolates. Morphology examination revealed flat biofilms with the exception of one isolate that demonstrated a mushroom-like biofilm. Matrix composition analysis showed the presence of proteins, beta-1,4 linked polysaccharides and extracellular DNA, but no poly-beta-1,6-N-acetyl-D-glucosamine. This study brings new information on the biofilm produced by C. perfringens and its exposure to low doses of antimicrobials.
产气荚膜梭菌是一种机会性病原体,可导致人类食物中毒和动物多种肠毒血症。关于产气荚膜梭菌生物膜及其对亚最低抑菌浓度抗菌药物的暴露,人们知之甚少。本研究旨在解决这些问题。在本研究中测试的大多数人类和动物产气荚膜梭菌分离株能够形成生物膜(230/277)。猪临床分离株形成的生物膜明显多于猪共生分离株。随机选择一组临床和共生产气荚膜梭菌分离株进行进一步表征。发现生物膜可保护产气荚膜梭菌细菌细胞免受测试抗菌药物的高浓度暴露。暴露于这些抗菌药物的低剂量下,生物膜的形成往往会减少。然而,少数分离株在暴露于低剂量的泰乐菌素、杆菌肽、维吉尼亚霉素和莫能菌素时,生物膜形成增加。随机选择六个分离株进行生物膜分析,使用扫描激光共聚焦显微镜。其中,有四个分离株在低剂量杆菌肽存在下产生更多的生物膜,而没有杆菌肽形成的生物膜更薄且凸起更少。在大多数分离株中,还观察到暴露于低剂量杆菌肽后生物膜中细菌所占面积增加。形态学检查显示生物膜呈扁平状,除一个分离株显示蘑菇状生物膜外。基质组成分析显示存在蛋白质、β-1,4 连接多糖和细胞外 DNA,但不存在聚-β-1,6-N-乙酰-D-葡萄糖胺。本研究提供了关于产气荚膜梭菌产生的生物膜及其对低剂量抗菌药物暴露的新信息。